C. Satish Chandran
Director/Board Member at STATERA BIOPHARMA, INC.
Profile
C.
Satish Chandran is the founder of Nucleonics, Inc. (founded in 2001) and Somahlution LLC (founded in 2010).
At Somahlution LLC, he holds the title of Chief Executive Officer & Director.
Dr. Chandran's current job(s) include being the Chief Executive Officer at Akshaya Bio, Inc. (since 2021), President & Chief Executive Officer at Lays Sciences, and Director at Statera Biopharma, Inc. In the past, Dr. Chandran worked as an Associate Professor at Thomas Jefferson University, a Professor at North Dakota State University (from 2010 to 2012), and as the President, Chief Operating & Technology Officer at Marizyme, Inc. (from 2020 to 2021).
Dr. Chandran obtained a doctorate degree from Memorial University of Newfoundland.
C. Satish Chandran active positions
| Companies | Position | Start |
|---|---|---|
| STATERA BIOPHARMA, INC. | Director/Board Member | 2022-02-23 |
Akshaya Bio, Inc.
 Akshaya Bio, Inc. Pharmaceuticals: MajorHealth Technology Akshaya Bio, Inc. develops therapeutics for infectious diseases and cancer. Its technology Chimigen platform to develop therapeutic vaccines for patients with chronic viral infections as well as prophylactic vaccines to prevent infections. The company was founded by Rajan George and is headquartered in Edmonton, Canada. | Chief Executive Officer | 2021-03-31 |
Somahlution LLC
 Somahlution LLC Medical DistributorsDistribution Services Somahlution LLC provides medical products focused on ischemia reperfusion injury using patented and proprietary technologies. It offers DuraGraft, one time intraoperative vascular graft treatment that maintains endothelial function and structure. The company was founded by Vithalbhai Dhaduk and C. Satish Chandran in 2010 and is headquartered in Jupiter, FL. | Founder | 2009-12-31 |
| Lays Sciences | Chief Executive Officer | - |
Former positions of C. Satish Chandran
| Companies | Position | End |
|---|---|---|
| MARIZYME, INC. | President | 2021-04-01 |
| North Dakota State University | Corporate Officer/Principal | 2011-12-31 |
| Thomas Jefferson University | Corporate Officer/Principal | - |
Nucleonics, Inc.
 Nucleonics, Inc. Pharmaceuticals: MajorHealth Technology Nucleonics, Inc. develops RNA interference-based therapeutics. It offers DNA vaccine programs. The company was founded in January 2001 and is headquartered in Horsham, PA. | Founder | - |
Training of C. Satish Chandran
| Memorial University of Newfoundland | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| MARIZYME, INC. | Health Technology |
| STATERA BIOPHARMA, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Nucleonics, Inc.
Nucleonics, Inc. Pharmaceuticals: MajorHealth Technology Nucleonics, Inc. develops RNA interference-based therapeutics. It offers DNA vaccine programs. The company was founded in January 2001 and is headquartered in Horsham, PA. | Health Technology |
Akshaya Bio, Inc.
Akshaya Bio, Inc. Pharmaceuticals: MajorHealth Technology Akshaya Bio, Inc. develops therapeutics for infectious diseases and cancer. Its technology Chimigen platform to develop therapeutic vaccines for patients with chronic viral infections as well as prophylactic vaccines to prevent infections. The company was founded by Rajan George and is headquartered in Edmonton, Canada. | Health Technology |
| Lays Sciences | |
Somahlution LLC
Somahlution LLC Medical DistributorsDistribution Services Somahlution LLC provides medical products focused on ischemia reperfusion injury using patented and proprietary technologies. It offers DuraGraft, one time intraoperative vascular graft treatment that maintains endothelial function and structure. The company was founded by Vithalbhai Dhaduk and C. Satish Chandran in 2010 and is headquartered in Jupiter, FL. | Distribution Services |
- Stock Market
- Insiders
- C. Satish Chandran
